Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Oleg Nodelman

Director at Aktis Oncology, Inc. (AKTS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-20.3%
vs. S&P 500-19.2%
Beat the market0%
Paper profit on buys+$333K
Total bought / sold$40.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jan 12SEC AKTSAktis Oncology, Inc. Buy 2,077,7794,348,658 held (+91%) $18.00 $37.4M +0.8%
Jan 12SEC AKTSAktis Oncology, Inc. Buy 144,443347,305 held (+71%) $18.00 $2.6M +0.8%
  • Buy

    Director Oleg Nodelman bought $37.4M of AKTS at $18.00 — first open-market purchase in our records; raises the stake by 91%.

  • Buy

    Director Oleg Nodelman bought $2.6M of AKTS at $18.00 — raises the stake by 71%.